CANCELLED: ESO-ESMO Baltic and Eurasia Masterclass in Clinical Oncology

On behalf of ESO and ESMO we would like to inform you that due to the ongoing Coronavirus (COVID-19) crisis we have made the difficult decision to cancel the ESO-ESMO Baltic and Eurasia Masterclass in Clinical Oncology programmed for 9-12 July in Tallinn, Estonia.

We deeply regret having to take this decision but we feel that in the current climate we all need to do our part in trying to limit the diffusion of the virus as much as possible and this was the only decision possible considering your role in society as medical staff.

We have discussed the possibility of postponing the event to later this year, but due to other already planned activities we have decided that postponing is not a viable solution.

We apologize for any inconvenience caused but we think you’ll all agree that this solution was unavoidable.

Chairs: N. Pavlidis, GR - F. Lordick, DE
Co-chairs: F. Peccatori, IT - V. Karaseva, RU
Host chair: A. Elme, EE

TEACHING FORMAT
The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic development. State-of-the-art data recognised by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour board basis and discuss them with the chairs and the faculty. Additional time will be allocated for participants to deliver case presentations within small groups and receive feedback.
As for all Masterclasses, the number of participants will be limited and admission will be by competitive application only.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

AIMS AND OBJECTIVES
This clinically oriented educational programme is designed for medical, clinical and radiation oncologists who wish to improve their skills in multidisciplinary care management.
The programme will expose participants to a full spectrum of issues in clinical oncology and practice-orientated training focusing on lung, genito-urinary, breast, head-and-neck, gastrointestinal, gynaecological cancers. Spotlight sessions will facilitate compact update on how to diagnose and treat neuroendocrine tumors, cancer of unknown primary, management of chemotherapy-induced nausea and vomiting, melanoma and communication skills.

THE MASTERCLASS IS
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on lung, genito-urinary, breast, head-and-neck, gastrointestinal and gynaecological cancers.



In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

• Download PDF document

FACULTY
G. Baciarello, Gustave Roussy Institute, Villejuif, FR
A. Elme, North Estonian Regional Hospital Cancer Centre, Tallinn, EE
A. Eniu, Cancer Institute Ion Chiricuta, Cluj Napoca, RO
F. Geara, American University of Beirut Medical Center, Beirut, LB
D. Hart, Cameron Communications, Bishops Stortford, UK
V. Karaseva, Russian National Medical Research University, named after N.I. Pigorov, Moscow, RU
E. Kharchenko, N.N. Petrov Research Institute of Oncology, Saint Petersburg, RU
M. Kuddu, North Estonian Regional Hospital Cancer Centre, Tallinn, EE
L. Licitra, IRCCS Foundation – National Cancer Institute, Milan, IT
F. Lordick, University Hospital Leipzig, DE
T. Metsaots, North-Estonia Medical Center, Tallinn, EE
K. Ojamaa, East Tallinn Central Hospital, EE
K. Oselin, Tartu University Hospital, Tartu, EE
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, University Hospital of Ioannina, GR
F. Peccatori, European Institute of Oncology (IEO), Milan, IT
G. Pruneri, IRCCS Foundation – National Cancer Institute, Milan, IT
K. Putnik, North Estonian Regional Hospital, Tallinn, EE
A. Richetti, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
M. Saretok, North Estonian Regional Hospital Cancer Centre, Tallinn, EE
C. Sessa, Oncology Institute of Southern Switzerland, Bellinzona, CH
A. Snegovoy, N.N. Blokhin Russian Cancer Research Center, Moscow, RU
R. Stahel, University Hospital Zurich, CH
S. Tjulandin, N.N. Blokhin Russian Cancer Research Center, Moscow, RU
C. Toumpanakis, Royal Free Hospital, London, UK
I. Tsimafeyeu, RUSSCO - Russian Society of Clinical Oncology, Kidney Cancer Research Bureau, Moscow, RU

ORGANISING SECRETARIAT
Alice Ciocchini
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464529
Fax: +39 02 85464545
Email: aciocchini@eso.net

Applications
Alice Ciocchini
Ph: +39 02 85464529
Email: aciocchini@eso.net

PARTICIPANT’S PROFILE OF THE MASTERCLASS CANDIDATE
• Age up to 40 years
• At least 2-3 years’ experience in medical or clinical oncology
• This event is designed to meet the educational needs of participants practicing in Baltic and Eurasian countries.
• Involvement in scientific activities
• Intermediate level of English

Priority will be given to applicants practicing in Baltic and Eurasian countries.

Participants will be asked to bring their personal laptop or tablet (wireless enabled) to the Masterclass as an event-dedicated website will be created and all questionnaires and certificates will be accessible only from there. Any potential problems with meeting this request should be communicated to the secretariat as part of the application process.

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
Successful applicants are granted free registration and accommodation
THE APPLICATION DEADLINE HAS PASSED (13 APRIL 2020)